CMS Finalizes New Mandatory Drug Payment Model To Deliver Lower Drug Prices For Beneficiaries In Original Medicare Part B
CMS announced the following on September 30, 2026: The Centers for Medicare & Medicaid Services (CMS) is finalizing a groundbreaking drug payment model to address the increasingly expensive cost of drugs in Original Medicare Part B while preserving or enhancing Medicare beneficiaries’ quality [...]